Market Size (2015)
2015
$62.10M
Vertical: HealthcareBase Year: 201714 Sections
Market Size (2015)
2015
$62.10M
Projected (2023)
2023
$951.94M
CAGR (2015–2023)
40.7%
40.7%Key Players
111+
This report covers CBD Hemp Oil Market with forecasts from 2015 to 2023. 111 key companies are profiled.
The CBD Hemp Oil Market market is projected to grow at a CAGR of 40.7% from 2015 to 2023.
Historical performance and future projections (2020–2030, USD Billion)
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansMarket Size (USD Mn)
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansHemp derived CBD oil:Cannabidiol (CBD) hemp oil is made from high-cannabidiol-containing hemp with a low tetrahydrocannabinol (THC) level. The CBD Hemp oil with low levels of THC are non-psychoactive in nature. CBD molecule interacts through the endocannabinoid system. These systems regulate the body’s appetite, immune response hormones, sleep, and mood.
CBD Capsule/Softgel:
CBD capsules are similar in comparison to capsules as they are surrounded by an outer shell, usually gelatin. CBD Soft gelatin capsule are translucent golden shade standard capsule that are filled with hemp oil and sometimes olive oil as filler.
CBD is a cannabinoid found in the cannabis plant. CBD oil acts as a natural pain reliever, have anti-inflammatory properties and could reduce epileptic seizures, etc. From the past few years, the market for CBD hemp oil had been increasing owing to rising legalization of cannabis and growing R&D in the field. Following the same, it is noted that new market players have been emerging in the market owing to the rising demand for CBD oil. All such factors are estimated to drive the market with a double-digit CAGR.
Note: The CBD oil derived from hemp is organic in nature and is available in its pure form. We have considered, hemp-derived CBD oil product segment along with CBD softgel capsules that are infused with CBD hemp oil.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansThis report applies a rigorous multi-stage research process combining primary interviews, secondary data sources, and bottom-up market modelling to ensure accuracy and completeness across all segments and geographies.
Base Year
2017
Historical Period
2015 – 2017
Forecast Period
2017 – 2023
Primary Interviews
150+
Historical data (2015–2017) and forecast period (2017–2023)
Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansMichael Porter’s five forces analysis determines the attractiveness and competitive intensity of the market. This is a useful tool to understand the strength of an organization’s current competitive position.
The five forces are very significant to develop strategy formulation. The potential of these forces varies from industry to industry. On combining these forces, the profitability of industry can be determined because it will help to shape up the prices that can be charged, the costs that can be borne, and the investment needed to compete in the industry. The five industry forces identified are the threat of new entrants, bargaining power of suppliers, bargaining power of buyers, the threat of substitutes, and rivalry among existing competitors.
The components of each of the forces and the degree or impact of each component in the context of the global CBD hemp oil industry have been broken down and analyzed below.Bargaining Power of Suppliers
Bargaining power of suppliers in the CBD hemp oil market is moderate. In the global CBD oil industry, suppliers are raw materials manufacturers and, intermediates. The number of suppliers in the market is less which limits the supply of hemp to product manufacturers for raw material sourcing, thus leaving suppliers with high bargaining power. Switching cost of these suppliers is also medium as the suppliers tend to enter into long-term associations with the manufacturers. One of the key dominant factors includes the introduction of Farm Bill which will encourage the farmers to cultivate more hemp. As Europe and China are the major cultivators of hemp the absence of one dominant supplier and availability of hemp from the black market increase the bargaining power of suppliers. On the other hand, since the production cost & expensive materials are used for manufacturing of CBD hemp oil, only a moderate number of viable raw material substitutes are available, which further boosts the bargaining power of suppliers in the market.
Threat of Substitutes
The threat of substitutes in the global CBD hemp oil market is high. There are a variety of hemp products available in the market containing CBD compound. Other than oil, the CBD hemp products are available in various forms such as a cream, capsule or soft gel, gummies and natural isolates providing the same medical benefits. These products are available as both prescription and over-the-counter medications in the market. Also, the rising awareness about numerous types of hemp products increases the risk of threat of substitutes in the market.
Threat of New Entrants
The threat of new entrants is moderate to high in the CBD hemp oil market. Previously this industry had only thing stopping new comers from entering the market is the approval required by the government as limited licenses are issued by the government. By means of the Farm Bill this issue has been resolved and an increase in the threat from the new entrant is anticipated in the CBD hemp oil market. The market is also characterized by a moderate degree of brand loyalty.
Bargaining Power of Buyers
The bargaining power of buyers is moderate in the CBD hemp oil market. Patients and hospitals are the major buyers for the market. The presence of buyers in the market is high due to the increasing prevalence of chronic conditions, and rising demand for CBD based products for the treatment purpose. In addition, buyers are price sensitive, which moderately affects their bargaining power in the market. There are a smaller number of manufacturers of CBD based products in the world, which also affects the bargaining power of buyers. Additionally, switching cost is moderate for buyers as many alternative treatments are available at an effective cost.
Intensity of Rivalry
The degree of competition in the global CBD hemp oil market is moderate to high. The high degree of product differentiation among existing players increases the intensity of rivalry in the market. CBD oil manufacturing companies are trying to develop less expensive drugs to make treatment more affordable in the developing region. Moreover, demand for CBD oil is many times higher than supply. So, it also decreases the intensity of the rivalry.
Market estimates by geography (2023)
InsightAmericas leads with $951.94M by 2023, while Asia Pacific is projected to grow fastest at a 40.9% CAGR.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription Plans| REGION | 2015 | 2017 | 2023 | CAGR | SHARE |
|---|---|---|---|---|---|
| Americas | $62.10M | $205.63M | $951.94M | 40.7% | 80% |
| Asia Pacific | $6.41M | $21.49M | $99.63M | 40.9% | 8% |
| Europe | $8.68M | $29.23M | $129.74M | 40.2% | 11% |
| Rest of the World | $1.02M | $3.38M | $14.62M | 39.5% | 1% |
| Total | $78.21M | $259.73M | $1.20B | 40.7% | 100% |
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansTotal Market Size
$1.20B
| APPLICATION | REVENUE ($B) | GROWTH RATE | MARKET PENETRATION |
|---|---|---|---|
| Others | $484.17M | 40.7% | 53% |
| Pain Relief | $416.50M | 40.7% | 89% |
| Neurological Disorders | $182.52M | 40.7% | 40% |
| Sleeping Disorders & Depression | $87.64M | 40.7% | 60% |
| Multiple Sclerosis | $25.12M | 40.7% | 77% |
* Revenue projections based on 2025 estimates. Growth rates represent CAGR 2024–2030. Market penetration indicates current adoption rate within addressable market segments.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSee plans for professionals or small and medium businesses.

Analytical insights on CBD Hemp Oil Market covering market dynamics, competitive landscape, and strategic outlook.
The CBD Hemp Oil Market market is projected to reach $951.94M by 2023, growing at 40.7% CAGR. The Others segment holds the largest share.
The global CBD hemp oil market is mainly driven by the rising research funding for cannabinoid research,
legalization of CBD in various regions, and the rising occurrence of chronic diseases and related complications. However, the adverse effects associated with cannabis and stringent government policies may slow the growth of the market.
There are many private and government organizations supporting the research and development for cannabinoids for medical purposes. Cannabis has numerous medicinal properties by which it can cure various diseases. According to the National Institute of Drug Abuse, May 2018 publication, in 2017, the National Institute of Health (NIH) supported 330 projects and spent USD 140 million on cannabinoid research and development. During this investment USD 36 million spent on 70 projects to examine the therapeutic properties of cannabinoids and USD 15 million on 26 projects centered on cannabinoid (CBD). Even in 2016, NIH spent USD 21 million studying therapeutic properties of cannabinoids.
Singapore known for the world's most stringent drug laws is also funding research projects on medical treatments containing synthetically-derived compounds of the cannabis plant. In 2017, the government-run National Research Foundation launched a program to research the therapeutic potential of cannabinoids. It is a part of the organization's USD 25 million initiative to promote the biotech industry in the South-East Asian nation. The main aim of the project is to identify genes to create synthetic cannabinoids, so researchers do not need to grow the cannabis plant.
From all the information, it is observed that the escalating research funding for CBD would boost the CBD oil market.
Cannabis and its derivative products are illegal in Asian countries, but the legal landscape is shifting in several countries. Despite the legal and cultural complications, some countries in Asia are potential markets for cannabidiol (CBD) products. For instance, in November 2018, the Public Health Ministry took the initiative to reclassify cannabis and change its status from a completely prohibited item in Thailand. The use of cannabis is illegal in Japan also, but research into cannabinoids is being undertaken with about 40 farmers given licenses to grow a low-THC strain of Cannabis called Tochigi Shiro.
Apart from the well proven medical advantages of Cannabis, they also have harmful effects on health. According to a 2017 study published in the Pharmacy and Therapeutics journal, heavy or long-term use of cannabis has led to addiction, altered brain development, diminished life satisfaction, cognitive impairment, and poor educational outcomes. It is also found that effects were more adverse in individuals who begin using cannabis-based products as adolescents. The current study has also reported that the most commonly reported non-serious adverse events were dizziness, with an occurrence rate of 15.5% among people exposed to cannabinoids. Long-term use of cannabis is also associated with an increased risk of chronic psychosis-related health disorders and chronic bronchitis.
From all the information, it can be concluded that the adverse effects associated with cannabis can strongly impact the growth of the market.
Near-term growth will likely concentrate in modular bioreactor lines and closed-system media workflows that shorten validation cycles while preserving batch traceability.
Partnerships between CDMOs and instrumentation vendors should accelerate standard datasets for comparability across sites, improving forecasting models used in capacity planning.
Longer horizon, organoid and microphysiological adoption may reshape segment mix; teams that invest early in assay interoperability and cloud QC hooks are better positioned to capture upside without fragmenting their analytics stack.
Profiles of 111 companies operating in the CBD Hemp Oil Market market, including revenue, employee count, and market positioning where available.
Showing 111 of 111 companies
Charlotte's Web Holdings Inc.
Company Headquarters: Boulder, Colorado US Founded: 2014 Workforce: 500 Company Working: Charlotte's Web Holdings Inc. is involved in the production and distribution of hemp-based, cannabidiol products. There are various products offered by the company which includes tinctures, capsules, and topical. The company distributes its products under Charlotte’s Web and CW names through an e-commerce website, wholesalers, and retailing shops. The company has 3680 retail locations for distributing its products. Earlier the company was known as Stanley Brothers Holdings Inc. and changed its name to Charlotte’s Web in July 2018.
Medical Marijuana Inc
Company Headquarters: California, US Founded: 2009 Workforce: ~50 Company Working: Medical Marijuana Inc. was the world’s first legal supplier of CBD. The company’s focus is on areas such as the development of the international CBD pipeline, the manufacturing of legal cannabis-based consumer products and drugs, and developing new markets for medical cannabis. It offers products such as hemp oils, cannabidiol drops, and tinctures for consumers. It also uses an online portal for the distribution of its products across the world.
Isodiol International Inc.
Company Headquarters: California, US Founded: 2014 Workforce: ~30 Company Working: Isodiol International Inc. is a leader in pharmaceutical grade phytochemical compounds and an industry leader in the manufacturing and development of consumer products. The company has commercialized naturally isolated CBD with micro-encapsulation and nanotechnology to develop quality consumable and topical skincare products. It offers supplements, vitamins, pharmaceuticals, and various nutraceutical products. The company’s product range involves daily products, CBD pet products, CBD sport products, and skin care products.
IrieCBD
Company Headquarters: California, US Founded: 2015 Company Working: IrieCBD is a US-based manufacturer of organic CBD-hemp extract products for improving health and wellness of patients suffering from various chronic conditions. The company has a reputation for a specialized line of tinctures.
Bluebird Botanicals LTD
Company Headquarters: Colorado, US Founded: 2012 Workforce: ~175 employees Company Working: Bluebird Botanicals LTD is a major manufacturer of high-quality Hemp Extracts and CBD oil. The company differentiates itself by producing high-quality CBD products. The company also performs extensive and transparent third-party testing.
ENDOCA
Company Headquarters: Amsterdam, Netherlands Founded: 2013 Workforce: ~100 Company Working: Endoca focuses on research and development to produce innovative hemp extracts and make them available across the globe. The company produces some of the finest and purest CBD oils and never compromise the quality. It invests a significant amount of revenue in strategic collaborations and funding for social projects. Endoca is regarded as a pioneer in the CBD industry since its products are made with 100% chemical-free components, free of fillers or other hidden extracts, and produced in a cutting-edge facility that complies with pharmaceutical rules. Moreover, the company has a dedicated manufacturing facility that complies with Good Manufacturing Practice (GMP). It delivers its products worldwide through its strong distribution network.
Powering the world's best teams.
From next-gen startups to established enterprises.
Trusted by forward-thinking businesses
for data-driven intelligence
CBD Hemp Oil Market